Related Experiment Video
Updated: Aug 13, 2026

Modeling Neural Immune Signaling of Episodic and Chronic Migraine Using Spreading Depression In Vitro
Published on: June 13, 2011
Migraine immune cell gene targets and their relationship to psychiatric disorders
Xin Mo1, Dongren Sun2, Fangfang Li3
1Department of Neurosurgery, The Second People's Hospital of Hunan Provincial (Hunan Provincial Brain Hospital), Changsha, 410011, China.
Background:
Migraine frequently co-occurs with psychiatric disorders, yet the immunogenetic mechanisms linking these conditions remain largely unexplored.
Methods:
Using cis-eQTL data from 28 immune cell subtypes (1,925 donors) and GWAS summary statistics for migraine and five psychiatric disorders, we performed single-cell transcriptome-wide Mendelian randomization, Bayesian colocalization, genetic correlation, and cross-disease pleiotropy analyses. Independent replication was performed using external datasets.
Results:
Migraine and its subtypes showed significant positive genetic correlations with all five psychiatric disorders (rg = 0.39-0.73). We identified 83 immune cell gene targets for migraine, 13 for migraine with aura, and 19 for migraine without aura. Among these, 6 targets showed shared associations with anxiety and 1 with depression. Three prioritized genes-HLA-A, CDK2AP1, and TTC24-demonstrated cross-disease pleiotropic effects. Notably, HLA-A in cDC1 exhibited discordant pleiotropy (protective for migraine with aura, risk for depression), with known drug-gene interactions involving antiepileptics and tricyclic antidepressants.
Conclusions:
These findings suggest that immune cell-specific genes, particularly HLA-A, CDK2AP1, and TTC24, may bridge migraine and psychiatric disorders, offering potential candidates for further investigation into shared immunogenetic mechanisms.
Clinical Trial Number:
Not applicable.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
